ICAM-1988 | CAS#444169-80-6 | LFA-1 antagonist

MedKoo Cat#: 596796 | Name: ICAM-1988

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ICAM-1988 is an LFA-1 antagonist.

Chemical Structure

ICAM-1988

CAS#444169-80-6

Theoretical Analysis

MedKoo Cat#: 596796

Name: ICAM-1988

CAS#: 444169-80-6

Chemical Formula: C22H22Cl2N4O6S

Exact Mass: 540.0637

Molecular Weight: 541.40

Elemental Analysis: C, 48.81; H, 4.10; Cl, 13.10; N, 10.35; O, 17.73; S, 5.92

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

ICAM-1988; ICAM 1988; ICAM1988;

IUPAC/Chemical Name

(S)-2-(2,6-dichloro-4-(((E)-3-(furan-2-yl)acrylamido)methyl)benzamido)-3-((R)-thiazolidine-4-carboxamido)propanoic acid

InChi Key

NKAQYHXMQJFUKQ-RYTMFUSVSA-N

InChi Code

InChI=1S/C22H22Cl2N4O6S/c23-14-6-12(8-25-18(29)4-3-13-2-1-5-34-13)7-15(24)19(14)21(31)28-16(22(32)33)9-26-20(30)17-10-35-11-27-17/h1-7,16-17,27H,8-11H2,(H,25,29)(H,26,30)(H,28,31)(H,32,33)/b4-3+/t16-,17-/m0/s1

SMILES Code

O=C(O)[C@H](CNC([C@H]1NCSC1)=O)NC(C2=C(Cl)C=C(CNC(/C=C/C3=CC=CO3)=O)C=C2Cl)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 541.40 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Velarde GP, Sherazi S, Kraemer DF, Bravo-Jaimes K, Butterfield R, Amico T, Steinmetz SD, Guzman M, Martin D, Dodani S, Smith BH. Clinical and Biochemical Markers of Cardiovascular Structure and Function in Women With the Metabolic Syndrome. Am J Cardiol. 2015 Dec 1;116(11):1705-10. doi: 10.1016/j.amjcard.2015.09.010. Epub 2015 Sep 16. PubMed PMID: 26482181. 2: Van der Donckt C, Roth L, Vanhoutte G, Blockx I, Bink DI, Ritz K, Pintelon I, Timmermans JP, Bauters D, Martinet W, Daemen MJ, Verhoye M, De Meyer GR. Fibrillin-1 impairment enhances blood-brain barrier permeability and xanthoma formation in brains of apolipoprotein E-deficient mice. Neuroscience. 2015 Jun 4;295:11-22. doi: 10.1016/j.neuroscience.2015.03.023. Epub 2015 Mar 19. PubMed PMID: 25797463. 3: Kirmizis D, Papagianni A, Dogrammatzi F, Belechri AM, Alexopoulos E, Efstratiadis G, Memmos D. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis. Ren Fail. 2012;34(9):1135-9. doi: 10.3109/0886022X.2012.717484. Epub 2012 Sep 6. PubMed PMID: 22950641. 4: Ganem F, Serrano CV Jr, Fernandes JL, Blotta MH, Souza JA, Nicolau JC, Ramires JA, Hueb WA. Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. Interact Cardiovasc Thorac Surg. 2011 May;12(5):778-83. doi: 10.1510/icvts.2010.255257. Epub 2011 Feb 5. PubMed PMID: 21297144. 5: Mendez MP, Monroy YK, Du M, Preston AM, Tolle L, Lin Y, VanDussen KL, Samuelson LC, Standiford TJ, Curtis JL, Beck JM, Christensen PJ, Paine R 3rd. Overexpression of sICAM-1 in the alveolar epithelial space results in an exaggerated inflammatory response and early death in Gram negative pneumonia. Respir Res. 2011 Jan 19;12:12. doi: 10.1186/1465-9921-12-12. PubMed PMID: 21247482; PubMed Central PMCID: PMC3034680. 6: Ottaviani C, Shapiro D, Davydov DM, Goldstein IB, Mills PJ. The autonomic phenotype of rumination. Int J Psychophysiol. 2009 Jun;72(3):267-75. doi: 10.1016/j.ijpsycho.2008.12.014. Epub 2009 Jan 15. PubMed PMID: 19272312. 7: Khojasteh SC, Leipold DD, Lai F, La H, Baumgardner MJ, Desino KE, Gudmundsson OS, Bloedow DC, Bodary SC, Reynolds ME, Gadek TR, Kenkare-Mitra S. Preclinical absorption, distribution, metabolism and excretion (ADME) characterization of ICAM1988, an LFA-1/ICAM antagonist, and its prodrug. Xenobiotica. 2008 Mar;38(3):340-52. doi: 10.1080/00498250701813248 . PubMed PMID: 18274961.